Overview

Update
Status
Acquired by on September 1, 2010
Total Equity Funding
$29M in 1 Round from 6 Investors
Headquarters:
Cambridge, MA
Description:
FoldRx Pharmaceuticals is focused on discovering and developing disease-modifying drug therapies for protein misfolding diseases.
Founders:
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.foldrx.com

Company Details

Update

FoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The companyТs pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson's disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts.

Funding Rounds (1) - $29M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2010$29M / Venture6

Current Team (1)

Update

Board Members and Advisors (2)

Update

News (3)

Update

Offices/Locations (1)

Update
  • Office

    100 Acorn Park Drive

    5th Floor

    Cambridge, MA 02140

    USA

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos